TransDigm CFO awarded performance-based stock options, 8,700 total

Rhea-AI Filing Summary

TransDigm Group (TDG) reported a Form 4 for CFO Sarah Wynne showing a grant of 8,700 stock options on 11/04/2025 with an exercise price of $1,291.97 per share.

The options vest 50% in 2029 and 50% in 2030, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. The filing lists direct ownership.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wynne Sarah

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	8,700	$0.00	--

Holdings After Transaction: Stock Option — 8,700 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wynne Sarah

(Last) (First) (Middle)

1350 EUCLID AVENUE

SUITE 1600

(Street)

CLEVELAND OH 44115

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TransDigm Group INC [ TDG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$1,291.97	11/04/2025		A		8,700		(1)	11/04/2035	Common Stock	8,700	$0	8,700	D

Explanation of Responses:

1. These options are exercisable at 50% per year in 2029 and 50% in 2030 subject to the achievement of annual operating performance targets in each year.

	/s/ Rachel Quinlan as attorney in fact for Sarah Wynne	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TransDigm (TDG) disclose in this filing?

A Form 4 reporting a grant of 8,700 stock options to CFO Sarah Wynne on 11/04/2025.

What is the exercise price of the options granted to TDG’s CFO?

The options have an exercise price of $1,291.97 per share.

When do the TDG CFO’s options vest?

They vest 50% in 2029 and 50% in 2030, subject to annual operating performance targets.

When do the options expire?

The options expire on 11/04/2035.

Is the ownership listed as direct or indirect?

The filing shows direct ownership of the derivative securities.

Was there any cash price paid for the option grant?

The filing shows a price of $0 for the derivative security, reflecting a grant.

Who is the reporting person in the TDG Form 4?

The reporting person is Sarah Wynne, Chief Financial Officer.